Angiotensin II Administration in Patients With COVID-19 Shock

Conclusions:

On average, the hemodynamic response to angiotensin II in COVID-19 related shock was favorable. Two patients had a marked rapid improvement. Given the relationship of SARS-CoV-2 with the renin-angiotensin-aldosterone system, further evaluation of angiotensin II for the treatment of COVID-19 related shock is warranted.

Source: Critical Pathways in Cardiology - May 27, 2021 Category: Cardiology Tags: Original Studies Source Type: research